Skip to search formSkip to main contentSkip to account menu

RTI 336

Known as: RTI-336 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336
Background: Preclinical and clinical data suggest that a compound which binds potently to and inhibits the dopamine transporter… 
2010
2010
Lower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primates
Highly Cited
2007
Highly Cited
2007
Effects of Combined Dopamine and Serotonin Transporter Inhibitors on Cocaine Self-Administration in Rhesus Monkeys
Dopamine transporter (DAT) inhibitors may represent a promising class of drugs in the development of cocaine pharmacotherapies… 
Review
2006
Review
2006
Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse
The discovery and preclinical development of selective dopamine reuptake inhibitors as potential pharmacotherapies for treating… 
2006
2006
Effects of dopamine transporter selective 3-phenyltropane analogs on locomotor activity, drug discrimination, and cocaine self-administration after oral administration.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)